Education
About Us
Working with TipRanks
Follow Us
Nike (NKE)
NYSE:NKE
NKE Analyst Ratings
Moderate Buy
12 Buy
9 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NKE Stock 12 Month Forecast
Average Price Target
$82.06
▲(18.40% Upside)
| Highest Price Target$115.00 | Average Price Target$82.06 | Lowest Price Target$64.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Raymond James
―
Hold
―
Reiterated
09/26/25
Goldman Sachs
$85
Buy
22.64%
Upside
Reiterated
09/25/25
Stifel Nicolaus
$64
Hold
-7.66%
Downside
Reiterated
09/25/25
Nike's Hold Rating: Balancing Strategic Shifts and Market ChallengesWe believe focus on performance innovation is the right strategy to restore appropriate lifestyle/performance balance. At a $71 share price, shares discount $2.84 EPS at a normalized 25x P/E multiple, which is in reach for FY27, but requires topline inflection and reacceleration to +MSD% revenue growth and graceful tariff navigation, for which visibility is difficult. We expect the turnaround is an eventuality, though believe investors are not being appropriately compensated for risk of a potentially elongated recovery period; reaffirm Hold. .
Telsey Advisory
$70→$75
Hold
8.21%
Upside
Reiterated
09/23/25
Bernstein
$90
Buy
29.85%
Upside
Reiterated
09/22/25
Morgan Stanley
$64→$70
Hold
1.00%
Upside
Reiterated
09/22/25
Hold Rating on Nike: Balancing Short-Term Positives with Long-Term UncertaintiesWe remain Equal-weight rated but have grown incrementally negative vs. 3M ago. While we think NKE’s poor fundamentals continue to get some degree of a pass N-T, we have grown incrementally negative on our Equal-weight thesis vs. 3M ago. This shift in view comes as 1) some components of the bull thesis that previously muted the bear case have moved in the wrong direction (i.e., positive channel checks are not materializing & the magnitude of rate of change seems less clear than 3M ago), & 2) valuation sits at elevated levels even on P/ E). Additionally, while mgmt.
Jefferies
$115
Buy
65.92%
Upside
Reiterated
09/22/25
UBS
$63→$71
Hold
2.44%
Upside
Reiterated
09/19/25
TR | OpenAI - 4o
$87→$78
Hold
12.54%
Upside
Downgraded
09/19/25
AI Generated ArticleAI Generated Article
Barclays
$64→$65
Hold
-6.22%
Downside
Reiterated
09/18/25
RBC Capital
$76→$90
Buy
29.85%
Upside
Upgraded
09/18/25
Bank of America Securities
$84
Buy
21.19%
Upside
Reiterated
09/17/25
Citi
$68→$74
Hold
6.77%
Upside
Reiterated
09/16/25
Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: VF (NYSE: VFC), Nike (NYSE: NKE) and Chewy (NYSE: CHWY)We expect a 1Q25 EPS beat (9/30 AMC) driven by stronger sales/lower SG&A. We expect mgmt to sound upbeat around new product innovation in performance running and reiterate their plan to get inventory clean by end of 2Q. Investors will be focused on consumer reception to new product this fall as a sign of whether NKE can build on their new product successes in 2H26. We expect investors to be focused on how spring’26 orderbooks look vs positive single-digit orderbooks this fall/holiday to gauge whether NKE’s cc sales can inflect positively in either 3Q/4Q. For 2Q, we expect mgmt to guide sales down ~$0.45-0.50 (cons $0.51). While NKE is seeing some early wins in running, we remain cautious on the sustainability of topline growth without visibility into a return to growth in key areas like basketball/sportswear (>50% of sales). We see a balanced risk/reward into 1Q EPS.
TD Cowen
$62→$85
Buy
22.64%
Upside
Upgraded
09/10/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Raymond James
―
Hold
―
Reiterated
09/26/25
Goldman Sachs
$85
Buy
22.64%
Upside
Reiterated
09/25/25
Stifel Nicolaus
$64
Hold
-7.66%
Downside
Reiterated
09/25/25
Nike's Hold Rating: Balancing Strategic Shifts and Market ChallengesWe believe focus on performance innovation is the right strategy to restore appropriate lifestyle/performance balance. At a $71 share price, shares discount $2.84 EPS at a normalized 25x P/E multiple, which is in reach for FY27, but requires topline inflection and reacceleration to +MSD% revenue growth and graceful tariff navigation, for which visibility is difficult. We expect the turnaround is an eventuality, though believe investors are not being appropriately compensated for risk of a potentially elongated recovery period; reaffirm Hold. .
Telsey Advisory
$70→$75
Hold
8.21%
Upside
Reiterated
09/23/25
Bernstein
$90
Buy
29.85%
Upside
Reiterated
09/22/25
Morgan Stanley
$64→$70
Hold
1.00%
Upside
Reiterated
09/22/25
Hold Rating on Nike: Balancing Short-Term Positives with Long-Term UncertaintiesWe remain Equal-weight rated but have grown incrementally negative vs. 3M ago. While we think NKE’s poor fundamentals continue to get some degree of a pass N-T, we have grown incrementally negative on our Equal-weight thesis vs. 3M ago. This shift in view comes as 1) some components of the bull thesis that previously muted the bear case have moved in the wrong direction (i.e., positive channel checks are not materializing & the magnitude of rate of change seems less clear than 3M ago), & 2) valuation sits at elevated levels even on P/ E). Additionally, while mgmt.
Jefferies
$115
Buy
65.92%
Upside
Reiterated
09/22/25
UBS
$63→$71
Hold
2.44%
Upside
Reiterated
09/19/25
TR | OpenAI - 4o
$87→$78
Hold
12.54%
Upside
Downgraded
09/19/25
AI Generated ArticleAI Generated Article
Barclays
$64→$65
Hold
-6.22%
Downside
Reiterated
09/18/25
RBC Capital
$76→$90
Buy
29.85%
Upside
Upgraded
09/18/25
Bank of America Securities
$84
Buy
21.19%
Upside
Reiterated
09/17/25
Citi
$68→$74
Hold
6.77%
Upside
Reiterated
09/16/25
Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: VF (NYSE: VFC), Nike (NYSE: NKE) and Chewy (NYSE: CHWY)We expect a 1Q25 EPS beat (9/30 AMC) driven by stronger sales/lower SG&A. We expect mgmt to sound upbeat around new product innovation in performance running and reiterate their plan to get inventory clean by end of 2Q. Investors will be focused on consumer reception to new product this fall as a sign of whether NKE can build on their new product successes in 2H26. We expect investors to be focused on how spring’26 orderbooks look vs positive single-digit orderbooks this fall/holiday to gauge whether NKE’s cc sales can inflect positively in either 3Q/4Q. For 2Q, we expect mgmt to guide sales down ~$0.45-0.50 (cons $0.51). While NKE is seeing some early wins in running, we remain cautious on the sustainability of topline growth without visibility into a return to growth in key areas like basketball/sportswear (>50% of sales). We see a balanced risk/reward into 1Q EPS.
TD Cowen
$62→$85
Buy
22.64%
Upside
Upgraded
09/10/25
Best Analysts Covering Nike
1 Month
xxx
Success Rate
23/38 ratings generated profit
Average Return
+1.32%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.53% of your transactions generating a profit, with an average return of +1.32% per trade.
3 Months
xxx
Success Rate
16/29 ratings generated profit
Average Return
+3.65%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 55.17% of your transactions generating a profit, with an average return of +3.65% per trade.
1 Year
2 Years
xxx
Success Rate
21/29 ratings generated profit
Average Return
+24.67%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 72.41% of your transactions generating a profit, with an average return of +24.67% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NKE Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
9
6
4
3
3
Buy
31
33
37
39
23
Hold
37
39
36
32
20
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
77
78
77
74
46
Each month's total comprises the sum of three months' worth of ratings.
NKE Financial Forecast
NKE Stock Forecast FAQ
What is NKE’s average 12-month price target, according to analysts?
Based on analyst ratings, Nike’s 12-month average price target is 82.06.
What is NKE’s upside potential, based on the analysts’ average price target?
Nike has 18.40% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NKE a Buy, Sell or Hold?
Nike has a consensus rating of Moderate Buy which is based on 12 buy ratings, 9 hold ratings and 0 sell ratings.
What is Nike’s price target?
The average price target for Nike is 82.06. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $115.00 ,the lowest forecast is $64.00. The average price target represents 18.40% Increase from the current price of $69.31.
The highest analyst price target is $115.00 ,the lowest forecast is $64.00. The average price target represents 18.40% Increase from the current price of $69.31.
What do analysts say about Nike?
Nike’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Streets Analysts.
How can I buy shares of NKE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.